LINC02682

Across TCGA pan-cancer cohorts, LINC02682 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC02682 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC02682 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02682 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SARC show a favorable association.

HNSC, LGG, and LAML are the cancer types where LINC02682 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	II,III,IV	0.722	0.309	.016	111	view →
LGG	OS	Tertile	All	0.560	0.830	<.001	51	view →
LAML	DFS	Tertile	All	0.111	0.572	.010	36	view →
BLCA	OS	Tertile	All	0.119	0.433	.024	18	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	18	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	18	view →
THYM	OS	Tertile	All	0.381	0.878	.017	12	view →
TGCT	OS	Tertile	All	0.934	0.992	.049	12	view →
PAAD	OS	Tertile	All	0.309	0.597	.020	9	view →
BRCA	OS	Tertile	II,III,IV	0.843	0.915	.019	6	view →
SARC	OS	Tertile	All	0.956	0.797	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC02682–HNSC (DFS)

Open the HNSC breakdown →